Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies

Fig. 3

Knockdown and Overexpression of E2F2. a, b qRT-PCR and Western blot analysis validating successful E2F2 knockdown in MGC cells using siRNA. c, d qRT-PCR and Western blot analysis validating successful E2F2 overexpression in MGC cells using lentiviral vectors.*P < 0.05; **P < 0.01; ***P < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us